Mackenzie Institute of Early Diagnosis > Publications
EBED 2024 – Programme
Wednesday 29 May
| Timeline | Topic |
|---|---|
| 1200-1300 | Arrival & Lunch |
| 1300-1315 | Welcome and introduction from Prof. Peter Donnelly |
| 1315-1415 | Setting the Scene: what could success look like for the introduction of new diagnostic tests? Patient Representative - Anne Fearfull Industry Representative - Andreas Halner, Oxford Cancer Analytics (OXcan) Journal Representative - Helen Macdonald, The British Medical Journal |
| 1415-1530 | Theoretical Considerations Dr. Margaret McCartney, University of St Andrews, Senior Lecturer. Freelance writer and broadcaster Prof. John Brodersen, University of Copenhagen, Department of Public Health 30 mins moderated panel discussion of 1st 2 sessions |
| 1530-1600 | BREAK |
| 1600-1645 | Abstract Session - Elevator Pitches Theoretical Considerations Gamuchirai Pamela Gwaza: Enhancing Early Diagnosis through Integrated Approaches: Practical Insights for Designing Interventions in LMICs - An Expert Consensus Huw Llewelyn: Assessing the use of tests for early diagnosis: predicting at what stage of disease progression the probability of benefit from treatment exceeds harm Clinical Perspective Ritah Nakiboneka: Deploying host transcriptional markers for diagnosis of tuberculosis Andrew Hall: The International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics (IMPACT): Using routinely-collected and audit-derived health data to evaluate and predict the effects of Coronavirus Disease 2019 on patients with a hip fracture Rishma Maini: Integrating liquid biopsies into Rapid Cancer Diagnostic Services University of St Andrews, St Andrews, United Kingdom Patient Perspective Simon Baldwin: Birmingham Self-test Report 1: Review of rapid self-test diagnostics sold in supermarkets and chemists in the UK: their descriptions, manufacturers, distributors, and regulators. Ridhi Agarwal: Birmingham Self-test Report 2: Are the statements of intended use and indicated medical actions for rapid self-test diagnostics sold in supermarkets and chemists appropriate? Bethany Hillier: Birmingham Self-test Report 3: What is the evidence base for claims of accuracy for rapid self-test diagnostics sold in UK retail settings? Jon Deeks: Birmingham Self-test Report 4: Are the equipment, sampling, and instructions of rapid self-test diagnostics sold in UK retail settings correct, usable and safe, and are documents readable and in line with national and international guidelines? Policy and Regulation Oscar Khawar: "Guidelines and regulations applicable to vitro diagnostic tests in the UK: a scoping review" |
| 1645-1700 | BREAK |
| 1700-1830 | Clinical Perspective Prof. Carl Heneghan, University of Oxford, Centre for Evidence-Based medicine Prof. Susan Moug, University of Glasgow, School of Medicine, Dentistry and Nursing Prof. Alex Richter, University of Birmingham, Institute of Immunology & Immunotherapy Discussion |
| 1830 | Drinks Reception in the Gateway, followed by walking tour of St Andrews led by University Students |
Thursday 30 May
| Timeline | Topic |
|---|---|
| 0715- | Beach run/swim with Dr. Margaret McCartney & Prof. Frank Sullivan – Meet at Gateway Building |
| 09-0930 | Networking coffee time, pastries, and bacon rolls |
| 0930-1030 | Policy and Regulations Prof. Jon Deeks, University of Birmingham, Institute of Applied Health Research Dr. Stuart Hogarth, University of Cambridge, Sociology Research Discussion |
| 1030-1100 | BREAK |
| 1100-1200 | Economic Issues Prof. Rebecca Fitzgerald, University of Cambridge, Department of Oncology Prof. Bethany Shinkins, University of Warwick Medical School Discussion |
| 1200-1315 | Lunch and networking |
| 1315-1430 | Oral Abstract Session - Theoretical considerations Martha Elwenspoek: Creating evidence-based optimal testing strategies for monitoring long-term conditions in primary care Katie Charlwood: What is the impact of regular monitoring with specific blood tests in people with long term conditions on patient outcomes? Trial emulation using routinely collected primary care data. Jacqueline Dinnes: Assessing the value of diagnostic tests: evaluation of a framework for identifying and organising test effects Sian Taylor-Phillips: Intermediate endpoints as sufficient surrogates for cancer-specific mortality in cancer screening trials: A systematic review and meta-analysis Stephen Bradley: Interpreting diagnostic accuracy studies based on retrospective routinely collected data Katerina-Vanessa Savva: Real world implementation of the Biomarker Toolkit: a Tool aiming to quantifiably assess biomarker utility and guide development |
| 1430-1500 | BREAK |
| 1500-1600 | Oral Abstract Session - Clinical & Patient Perspective Clare Turnbull: Polygenic risk stratification for breast, colorectal and prostate cancer screening in the UK: integration of multiple national routinely collected cancer datasets for modelling of potential impact on cancer-specific mortality Frank Sullivan: 5 year mortality in a Randomized Controlled Trial of an autoantibody biomarker for Lung cancer. Obaid Kousha: Pragmatic and scalable diabetic retinopathy screening for lower resource settings: Binocular indirect ophthalmoscopy versus a retinal camera, including Artificial Intelligence (AI) interpretation in Indonesia Alexandra Brandt Ryborg Jønsson: Logics of Time and Diagnosis |
| 1600-1730 | Meet the expert Sessions FS Facilitators: 1. Associate Prof. Brian Nicholson, Nuffield Department of Primary Care Health Symplify Sciences, University of Oxford a. How should we evaluate novel cancer 2. Prof. Clare Turnbull, The Institute of Cancer Research Polygenic testing a. What can polygenic testing contribute to ED 3. Prof. Jon Deeks,, University of Birmingham, Institute of Applied Health Research a. Pioneering Innovations: Direct-to-Consumer Tests in Modern Healthcare Pathways 4. Frank Sullivan, Biomarkers a. A doctoral training programme in Early Diagnosis? 5. Chris Peters, Biomarkers a. Why so few biomarkers make it into clinical practice. |
| 1730-1800 | Tour of Medicine Building |
| 1900 | Conference dinner |
Friday 31 May
| Timeline | Topic |
|---|---|
| 0900-0930 | Networking coffee time |
| 0930-1030 | Oral Abstract Session - Clinical Perspective & Policy & Regulation Sarah Mills: Developing A Risk Prediction Tools For Near Term Mortality In Patients Who Present To Unscheduled Care In Scotland Clare Davenport: Developing guidance for the evaluation, regulation, marketing, and monitoring of Direct to Consumer Tests (DTCTs)- ‘GUIDE DTCTs’ Allyson Pollock: Global burden of disease estimates for Major Depressive Disorder: instruments used in studies to measure prevalence of MDD not designed for that purpose, contribute to risk of over-diagnosis and over-treatment. James Larkin: Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: an observational study |
| 1030-1200 | Feedback from Meet the experts small group discussions - Identifying gaps and how to take forward |
| 1200-1300 | Summary and Future Planning |
| 1300-1400 | Lunch, Safe journey home |
